Research in CBD

The Endocannabinoid System, Cannabinoids, and Pain

Perry G. Fine, M.D. and Mark J. Rosenfeld, M.S., Ph.D.

The role of endocannabinoids in the hypothalamic regulation of visceral function

Wenger T, Moldrich G.

Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa.

de Mello Schier AR, de Oliveira Ribeiro NP, Coutinho DS, Machado S, Arias-Carrión O, Crippa JA, Zuardi AW, Nardi AE, Silva AC

Cannabis, Cannabinoids, and Sleep: a Review of the Literature.

Babson KA, Sottile J, Morabito D.

Neurobiological Underpinnings of the Estrogen – Mood Relationship

Whitney Wharton, Ph.D., Carey E. Gleason, Ph.D., Sandra R. M. S. Olson,  Cynthia M. Carlsson, M.D., M.S., Sanjay Asthana, M.D., F.R.C.P.

Cannabinoids in the management of difficult to treat pain

Ethan B Russo

Estrogen deficiency and bone loss: an inflammatory tale

M. Neale Weitzmann and Roberto Pacifici

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

JavierFernández-Ruiz, JuliánRomero, GuillermoVelasco, Rosa M.Tolón, José A.Ramos, ManuelGuzmán

Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration

Takeda S1, Okajima S, Miyoshi H, Yoshida K, Okamoto Y, Okada T, Amamoto T, Watanabe K, Omiecinski CJ, Aramaki H.

Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer

Zahida Qamri, Anju Preet, Mohd W. Nasser, Caroline E. Bass, Gustavo Leone, Sanford H. Barsky and Ramesh K. Ganju

Cannabinoids: A new hope for breast cancer therapy?

María M.Caffarel, Clara Andradas, Eduardo Pérez-GómezManuel, Guzmán Cristina Sánchez

Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents

SimonaPisantiPhD, Anna MariaMalfitanoPhD, ClaudiaGrimaldiPhD, AntoniettaSantoroPhD, PatriziaGazzerroPhD, ChiaraLaezzaPhD, MaurizioBifulcoMD

The endocannabinoid signaling system in cancer

SimonaPisanti,, PaolaPicardi,,AlbaD’Alessandro, Chiara Laezza,,Maurizio Bifulco

Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion

Mohd W. Nasser , Zahida Qamri , Yadwinder S. Deol, Diane Smith, Konstantin Shilo, Xianghong Zou, Ramesh K. Ganju

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation

Luciano De Petrocellis, Dominique Melck, Antonella Palmisano, Tiziana Bisogno, Chiara Laezza, Maurizio Bifulco, and Vincenzo Di Marzo

Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation

Dominique Melc, Luciano De Petrocellis, Pierangelo Orlando,Tiziana Bisogno,Chiara Laezza, Maurizio Bifulco, Vincenzo Di Marzo

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

JavierFernández-Ruiz, JuliánRomero, GuillermoVelasco, Rosa M.Tolón, José A.Ramos, ManuelGuzmán

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells

Sean D. McAllister, Rigel T. Christian, Maxx P. Horowitz, Amaia Garcia and Pierre-Yves Desprez

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

Michèle Arnone, Jeanne Maruani, Frédérique Chaperon, Marie-Hélène Thiébot, M. Poncelet, Philippe Soubrié, Gérard Le Fur

Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence: Results From a Placebo-Controlled, Double-Blind Trial

Soyka, Michael MD, Koller, Gabriele MD, Schmidt, Peggy PhD, Lesch, Otto-Michael MD, Leweke, Markus MD, Fehr, Christoph MD, Gann, Horst MD, Mann, Karl F. MD

Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview

B.S. Bassavarajappa & B.L. Hungund

Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction

Carl R.Lupica & Arthur C.Riegel

Blockade of the Cannabinoid CB1 Receptor and Alcohol Dependence: Preclinical Evidence and Preliminary Clinical Data

Maccioni, Paola; Colombo, Giancarlo; Carai, Mauro A.M.

Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans

H Ishiguro, S Iwasaki, L Teasenfitz, S Higuchi, Y Horiuchi, T Saito, T Arinami & E S Onaivi

Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders

Basalingappa L Hungund& K Yaragudri Vinod

Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol‐induced dopamine release in the nucleus accumbens

Basalingappa L. Hungund , Istvan Szakall , Agota Adam , Balapal S. Basavarajappa , Csaba Vadasz

A Critical Role for the Cannabinoid CB1 Receptors in Alcohol Dependence and Stress-Stimulated Ethanol Drinking

Ildiko Racz, Andras Bilkei-Gorzo, Zsuzsanna E. Toth, Kerstin Michel, Miklós Palkovits and Andreas Zimmer

The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats

Salvatore Serra, MauroA.Mcarai GiulianaBrunetti, RaquelGomezc, amueleMelis, GiovanniVacca, GiancarloColombo,, Gian Luigi Gessa

© 2019 C-Beyond Health LLC All Rights Reserved

C-Beyond Health LLC

West Colfax Ave

Golden CO 80401